Small Molecules Acquired in 2021 M&A: Deep Dive

There were 16 acquisitions of companies with small molecule drug assets in 2021 and one merger. Here is a more in-depth look into all of the lead small molecules acquired in 2021, including a review of: 

  • The lead molecules in each acquisition and their structural representations where disclosed
  • The mechanism of action, stage, and indication of each lead molecule
  • Relevant clinical data and rationale for each acquisition

get free samples and a Premium trial

Premium members get access to our library of hundreds of in-depth reviews on key molecules, ten new reviews each month, novel drug approval coverage, drug discovery company updates, and more:


Navigate the 2021 M&A Series

Join the Drug Hunter mailing list

to get free content and resources weekly. Trusted by > 5,500 drug hunters worldwide. Unsubscribe anytime.

Newsletter

Join Subscribers from